TissueCypher is Castle’s precision medicine risk-stratification test that predicts a patient’s individual risk of progression from Barrett’s esophagus (BE) to esophageal cancer Castle ...

Castle Biosciences has released data from a multi-centre DECIDE study showing the impact of integrating its DecisionDx-Melanoma test results into clinical decision-making in melanoma patients.

Did you know that quizzes can boost your memory, sharpen your focus, and expand your knowledge in just a few minutes? Whether ...

Statewide numbers suggest student test scores have flatlined in Hawaii in recent years, but results for individual schools ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating ...

Castle Industrial has opened 'one of the UK's most comprehensive static packaging test centres.' The Carnforth-based company has invested £500,000 in the new facility, which boasts an array of ...

When Gregg Popovich announced before the game that Spurs backup point guard Tre Jones would be out for two weeks with an ankle injury, expectations rose that rookie Stephon Castle would get more ...

Like a scene out of Scooby Doo, the group of 12 trainee guide dogs visited Warwick Castle's Halloween trail as a way to prepare them for remaining calm in unusual environments, where the ...

The Queensland Police Union has proposed extraordinary domestic violence reforms, designed to streamline protection orders and drastically reduce workloads of those on the frontline.

About TissueCypher® Barrett’s Esophagus Test The TissueCypher Barrett’s Esophagus test is Castle’s precision medicine test designed to predict future development of high-grade dysplasia ...

TissueCypher is Castle’s precision medicine risk-stratification test that predicts a patient’s individual risk of progression from Barrett’s esophagus ...